Evidence map›Paper›PMID 38117986›Full record

ArticleNucleic acids research2024

A phage-encoded RNA-binding protein inhibits the antiviral activity of a toxin-antitoxin system.

Chantal K Guegler, Gabriella I C Teodoro, Sriram Srikant, Keerthana Chetlapalli, Christopher R Doering, Dia A Ghose, Michael T Laub

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. V- and VNature communications · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chantal K GueglerDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Gabriella I C TeodoroDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Sriram SrikantDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Keerthana ChetlapalliDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Christopher R DoeringDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Dia A GhoseDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Michael T LaubDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0002-8288-7607
Massachusetts Institute of Technology · USHarvard University · USHoward Hughes Medical Institute · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Bacteria harbor diverse mechanisms to defend themselves against their viral predators, bacteriophages. In response, phages can evolve counter-defense systems, most of which are poorly understood. In T4-like phages, the gene tifA prevents bacterial defense by the type III toxin-antitoxin (TA) system toxIN, but the mechanism by which TifA inhibits ToxIN remains unclear. Here, we show that TifA directly binds both the endoribonuclease ToxN and RNA, leading to the formation of a high molecular weight ribonucleoprotein complex in which ToxN is inhibited. The RNA binding activity of TifA is necessary for its interaction with and inhibition of ToxN. Thus, we propose that TifA inhibits ToxN during phage infection by trapping ToxN on cellular RNA, particularly the abundant 16S rRNA, thereby preventing cleavage of phage transcripts. Taken together, our results reveal a novel mechanism underlying inhibition of a phage-defensive RNase toxin by a small, phage-encoded protein.

Indexed as

BacteriophagesToxin-Antitoxin SystemsAntitoxinsEndoribonucleasesRNA, Ribosomal, 16SAntitoxinsEndoribonucleasesRNA, Ribosomal, 16S

Identifiers

PMID38117986
PMCPMC10853763
OpenAlexW4390037842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.